article thumbnail

Lupin acquires nine brands of Medical Nutritional Institute in South Africa

Express Pharma

This acquisition broadens our product range by concentrating on metabolic diseases such as cardiovascular disease, diabetes, and neuroscience, thereby enhancing patient health and well-being.” Mariaan du Plessis, CEO of MNI , shared her excitement about joining Pharma Dynamics. “We

article thumbnail

PharmaShots Weekly Snapshots (March 27 - 31, 2023)

PharmaShots

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Minority Health: The Importance of Patient Navigation and Access to Timely Care

Putting Patients First Blog

Washington (DC): National Academies Press (US); 2002. Similar patient experiences are supported by the 2003 Institute of Medicine’s (IOM) findings in Unequal Treatment that documented disparities in clinical interventions. 2 Unfortunately, health outcome indicators are still demonstrating inequities. [link]. DOI: [link].

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. Diabetic Neuropathy Diabetic neuropathy, a common complication of long-term high blood sugar and insulin resistance, can cause constipation. Curr Opin Endocrinol Diabetes Obes.

article thumbnail

The Ultimate Guide To Using Enzymes with Hashimoto’s

The Thyroid Pharmacist

A poster presentation from April 21-24, 2002 presented in Cannes, France, found that Wobenzym , a proprietary blend of systemic enzymes, taken at a dose of five capsules, three times per day, showed very promising results in Hashimoto’s. ( * Wobenzym N is the formulation that was studied. Diabetic nephropathy. Joint pain. Inflammation.

article thumbnail

Hashimoto’s and Graves’ Remission after Helicobacter Pylori Eradication

The Thyroid Pharmacist

This big news was newly emerging research in 2002 when I started pharmacy school, 20 years after their initial discovery. J Diabetes Res. Finally, in 1994, the National Institutes of Health stated that most ulcers were in fact caused by H. pylori , and recommended the use of antibiotics for the treatment of ulcers. doi:10.7759/cureus.3062.

article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Company: AstraZeneca First Approval Date: Jul 31, 2009 Generic Name: Saxagliptin Patent Expiration: Jan 2023 2022 Sales: $257M Indication: Type 2 Diabetes Mellitus Onglyza is a member of the dipeptidyl peptidase-4 inhibitor class of oral hypoglycemics used combined with diet and exercise for managing type 2 diabetes.